United States - English - NLM (National Library of Medicine)

ion pharma, llc - methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz) - topical analgesic temporarily relieves aches & pains of muscles & joints associated with: - strains - sprains - simple backache - arthritis - bruises

United States - English - NLM (National Library of Medicine)

abbp (arrington, battle, bell & perry), llc - methyl salicylate (unii: lav5u5022y) (methyl salicylate - unii:lav5u5022y), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - methyl salicylate 30 ml in 100 ml - topical analgesic for the temporary relief of minor aches and pains of muscles and joints associated with simple backaches, arthritis, bruises, sprains and strains. - condition worsens - symptoms persist for more than seven (7) days - symptoms clear up and occur again within a few days.

United States - English - NLM (National Library of Medicine)

tianjin tianyao pharmaceuticals co., ltd. - methylprednisolone (unii: x4w7zr7023) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone tablets are indicated in the following conditions: 1. endocrine disorders primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). congenital adrenal hyperplasia nonsuppurative thyroiditis hypercalcemia associated with cancer 2. rheumatic disorders as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy) ankylosing spondylitis acute and subacute bursitis synovitis of osteoarthritis acute nonspecific tenosynovitis post-traumatic osteoarthritis psoriatic arthritis epicondylitis acute gouty arthritis 3. collagen diseases during an exacerbation or as maintenance therapy in selected cases of: systemic lupus erythematos

United States - English - NLM (National Library of Medicine)

pharmadel llc - methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz) - methyl salicylate 10.5 g in 100 g - purpose external analgesic uses for the temporary relief of minor aches and pains of muscles and joints associated with: - simple backache - arthritis - strains - sprains do not use - with a heating pad - with a tight bandage - on eyes, mucos membranes  - on broken or irritated skin stop use and ask doctor immediately if - if condition worsens or if symptoms persist for more than 7 days or clear up and occur again within a few days

United States - English - NLM (National Library of Medicine)

sandoz inc - methylprednisolone (unii: x4w7zr7023) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone 4 mg - methylprednisolone tablets are indicated in the following conditions: primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoids supplementation is of particular importance). congenital adrenal hyperplasia nonsuppurative thyroiditis hypercalcemia associated with cancer as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy) ankylosing spondylitis acute and subacute bursitis synovitis of osteoarthritis acute nonspecific tenosynovitis post-traumatic osteoarthritis psoriatic arthritis epicondylitis acute gouty arthritis during an exacerbation or as maintenance therapy in selected cases of: systemic lupus erythematosus systemic dermatomyositis (polymyositis) acute rheumatic cardit

United States - English - NLM (National Library of Medicine)

ningbo sante ying medicaland healthdevelopment co.,ltd - methyl salicylate 20%, menthol usp 10%, capsaicin 0.002% - topical analgesic provides soothing cold to sore muscles and joints if irritation occurs, ask a health professional before use if pregnant or brastfeeding. before using if you have sensitive skin.

United States - English - NLM (National Library of Medicine)

mckesson corporation dba sky packaging - methylprednisolone (unii: x4w7zr7023) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone 4 mg - methylprednisolone tablets are indicated in the following conditions: 1. endocrine disorders primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). congenital adrenal hyperplasia nonsuppurative thyroiditis hypercalcemia associated with cancer 2. rheumatic disorders as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy) ankylosing spondylitis acute and subacute bursitis synovitis of osteoarthritis acute nonspecific tenosynovitis post-traumatic osteoarthritis psoriatic arthritis epicondylitis acute gouty arthritis 3. collagen diseases during an exacerbation or as maintenance therapy in selected cases of: systemic lupus erythematos

United States - English - NLM (National Library of Medicine)

sagent pharmaceuticals - methylprednisolone sodium succinate (unii: lec9gky20k) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone 40 mg in 1 ml - when oral therapy is not feasible, and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intravenous or intramuscular use of methylprednisolone sodium succinate for injection is indicated as follows: allergic states: control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. dermatologic diseases: bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome). endocrine disorders: primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particula

United States - English - NLM (National Library of Medicine)

emami limited - methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz), menthol, unspecified form (unii: l7t10eip3a) (menthol, unspecified form - unii:l7t10eip3a) - - redness over the affected area - sensitive skin for the temporary relief of minor aches and pains of muscles and joints associated with - simple backache - bruises - strains - arthritis - sprains - condition worsens or symptoms persist for more than 7 days - symptoms clear up and occur again within a few days topical analgesic

United States - English - NLM (National Library of Medicine)

royal labs natural cosmetics, inc. - menthol 10%, methyl salicylate 10%, camphor bark oil 3%, eucalyptus leaf 2% - directions: adults and children 12 years of age and older: rub onto affected area 3 to 4 times daily; children under 12 years of age ask a doctor. for temporary relief of minor aches and pains of muscles associated with arthritis, muscle strain, bruises, sprains, backache